Real-world comparison of cabazitaxel vs. 177-lutetium-PSMA radioligand therapy in metastatic castration resistant prostate cancer.

被引：0
|
作者：
Wenzel, Mike
Koll, Florestan
Hoeh, Benedikt
Humke, Clara
Siech, Carolin
Mader, Nicolai
Groener, Daniel
Steuber, Thomas
Graefen, Markus
Maurer, Tobias
Brandts, Christian H.
Banek, Severine
Chun, Felix
Mandel, Philipp
机构：
[1] Univ Hosp Frankfurt, Dept Urol, Frankfurt, Germany
[2] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Urol, Frankfurt, Germany
[3] Univ Hosp Frankfurt, Dept Nucl Med, Frankfurt, Germany
[4] Goethe Univ Frankfurt, Dept Nucl Med, Frankfurt, Germany
[5] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, Hamburg, Germany
[6] Prostate Canc Ctr Hamburg, Martini Clin, Hamburg, Germany
[7] Goethe Univ Frankfurt, Frankfurt, Germany
[8] Goethe Univ Frankfurt, Dept Urol, Frankfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.70
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
    Wenzel, Mike
    Koll, Florestan
    Hoeh, Benedikt
    Humke, Clara
    Siech, Carolin
    Mader, Nicolai
    Sabet, Amir
    Groener, Daniel
    Steuber, Thomas
    Graefen, Markus
    Maurer, Tobias
    Brandts, Christian
    Banek, Severine
    Chun, Felix K. H.
    Mandel, Philipp
    JOURNAL OF NUCLEAR MEDICINE, 2025, 66 (01) : 61 - 66
  • [2] The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study
    Almuradova, Elvina
    Seyyar, Mustafa
    Arak, Haci
    Tamer, Fatih
    Kefeli, Umut
    Koca, Sinan
    Sen, Erdem
    Telli, Tugba Akin
    Karatas, Fatih
    Gokmen, Ivo
    Turhal, Nazim Serdar
    Sakalar, Teoman
    Ayhan, Murat
    Ekinci, Ferhat
    Hafizoglu, Emre
    Kahraman, Seda
    Kesen, Oguzhan
    Unal, Caglar
    Alan, Ozkan
    Celik, Serdar
    Yekeduz, Emre
    Omur, Ozgur
    Gokmen, Erhan
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (04) : 692 - 700
  • [3] Real-World Data Analysis of Efficacy and Survival After Lutetium-177 Labelled PSMA Ligand Therapy in Metastatic Castration-Resistant Prostate Cancer
    Meyrick, Danielle
    Gallyamov, Marat
    Sabarimurugan, Shanthi
    Falzone, Nadia
    Lenzo, Nat
    TARGETED ONCOLOGY, 2021, 16 (03) : 369 - 380
  • [4] Real-World Data Analysis of Efficacy and Survival After Lutetium-177 Labelled PSMA Ligand Therapy in Metastatic Castration-Resistant Prostate Cancer
    Danielle Meyrick
    Marat Gallyamov
    Shanthi Sabarimurugan
    Nadia Falzone
    Nat Lenzo
    Targeted Oncology, 2021, 16 : 369 - 380
  • [5] 177Lutetium PSMA radioligand therapy in prostate cancer
    Vis A.N.
    Jansen B.H.E.
    Bodar Y.J.L.
    Nieuwenhuijzen J.A.
    Hendrikse H.N.
    Oprea-Lager D.E.
    Tijdschrift voor Urologie, 2020, 10 (4) : 60 - 65
  • [6] Early side effects of radio ligand therapy with 177-Lutetium-PSMA of metastatic castrate-resistant prostate cancer
    Ahmadzadehfar, H.
    Yordanova, A.
    Kuerpig, S.
    Eppard, E.
    Gaertner, F.
    Rogenhofer, S.
    Essler, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S722 - S723
  • [7] Early side effects of radio ligand therapy with 177-Lutetium-PSMA of metastatic castrate-resistant prostate cancer
    Ahmadzadehfar, Hojjat
    Rahbar, Kambiz
    Kuerpig, Stefan
    Boegemann, Martin
    Claesener, Michael
    Eppard, Elisabeth
    Gaertner, Florian
    Rogenhofer, Sebastian
    Schaefers, Michael
    Essler, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [8] Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    Sartor, Oliver
    de Bono, Johann
    Chi, Kim N.
    Fizazi, Karim
    Herrmann, Ken
    Rahbar, Kambiz
    Tagawa, Scott T.
    Nordquist, Luke T.
    Vaishampayan, Nitin
    El-Haddad, Ghassan
    Park, Chandler H.
    Beer, Tomasz M.
    Armour, Alison
    Perez-Contreras, Wendy J.
    DeSilvio, Michelle
    Kpamegan, Euloge
    Gericke, Germo
    Messmann, Richard A.
    Morris, Michael J.
    Krause, Bernd J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12): : 1091 - 1103
  • [9] Lu-177 PSMA Radioligand Therapy as Salvage Treatment in Metastatic Castration-Resistant Prostate Cancer
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Langbein, T.
    Zhang, J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S287 - S288
  • [10] Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    Hadaschik, Boris
    Herrmann, Ken
    EUROPEAN UROLOGY, 2021, 80 (04) : 520 - 521
12345